Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

Elham Rashidghamat, Tendai Kadiyirire, Salma Ayis, Gabriela Petrof, Lu Liu, Venu Pullabhatla, Chrysanthi Ainali, Alyson Guy, S Aristodemou, James R. McMillan, L Ozoemena, John Mee, Rashida Pramanik, Alka Saxena, Rosamond Nuamah, Emanuele de Rinaldis, Sonia Serrano, Clarisse Maurin, Magdalena Martinez-Queipo, Su LwinDusko Ilic, Anna E. Martinez, Francesco Dazzi, Ineke Slaper-Cortenbach, Kasper Westinga, Sabrina Zeddies, Marcel van den Broek, Alexandros Onoufriadis, J Mellerio, John A. McGrath

Research output: Contribution to journalArticlepeer-review

59 Citations (Scopus)
1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa'. Together they form a unique fingerprint.

Medicine and Dentistry